key: cord-0018542-0eh5m1y0
authors: Chowdhury, Umar Faruq; Saba, Abdullah Al; Sufi, Abu Sufian; Khan, Akib Mahmud; Sharmin, Ishrat; Sultana, Aziza; Islam, Md Ohedul
title: Subtractive proteomics approach to Unravel the druggable proteins of the emerging pathogen Waddlia chondrophila and drug repositioning on its MurB protein
date: 2021-06-16
journal: Heliyon
DOI: 10.1016/j.heliyon.2021.e07320
sha: 457410adbe43852742c64efd54dd694d194b4cd3
doc_id: 18542
cord_uid: 0eh5m1y0

Waddlia chondrophila is an emerging pathogen that has been implicated in numerous unpropitious pregnancy events in humans and ruminants. Taking into account its association with abortigenic events, possible modes of transmission, and future risk, immediate clinical measures are required to prevent widespread damage caused by this organism and hence this study. Here, a subtractive proteomics approach was employed to identify druggable proteins of W. chondrophila. Considering the essential genes, antibiotic resistance proteins, and virulence factors, 676 unique important proteins were initially identified for this bacterium. Afterward, NCBI BLASTp performed against human proteome identified 223 proteins that were further pushed into KEGG Automatic Annotation Server (KAAS) for automatic annotation. Using the information from the Kyoto Encyclopedia of Genes and Genomes (KEGG) database 14 Waddlia specific metabolic pathways were identified with respect to humans. Analyzing the data from KAAS and KEGG databases, forty-eight metabolic pathway-dependent, and seventy metabolic pathway independent proteins were identified. Standalone BLAST search against DrugBank FDA approved drug targets revealed eight proteins that are finally considered druggable proteins. Prediction of three-dimensional structures was done for the eight proteins through homology modeling and the Ramachandran plot model showed six models as a valid prediction. Finally, virtual screening against MurB protein was performed using FDA approved drugs to employ the drug repositioning strategy. Three drugs showed promising docking results that can be used for therapeutic purposes against W. chondrophila following the clinical validation of the study.

Emerging Infectious Diseases (EID) and Re-Emerging Infectious Diseases can be a great threat to microbiological public health and can have a large impact on socio-economical aspects [1] . An emerging pathogen can be characterized as the causative agent of an infectious disease whose frequency is expanding following its appearance either in the current host or in another host population because of long-term changes in its fundamental epidemiology [1] . Environmental changes, natural disasters, large population size are some of the key factors that have a significant contribution to the emergence and spread of infectious diseases [2, 3, 4, 5] .

Waddlia chondrophila, a member of the Chlamydiales order, is an emerging pathogen that has gained attention over the years for showing implications in human and ruminant diseases [6, 7] . According to genomic and growth studies, it shows many similarities with some other well-characterized zoonotic chlamydial abortifacients (pathogen cause abortion), such as Chlamydia abortus [8] . Association between W. chondrophila and adverse pregnancy outcomes on women who had experienced sporadic or recurrent miscarriage has been repeatedly observed [9, 10, 11, 12, 13] . Viability and mitochondrial membrane potential of human spermatozoa were reduced when challenged and infected with W. chondrophila [14] . Studies also showed a high seroprevalence of W. chondrophila in men of infertile couples although the organism was seemed to be absent in semen which suggested a possible hypothesis that the negative effect on male infertility may be observed only during an ongoing infection [15] . The organism was shown to replicate in several human cell lines including fibroblasts, A549 pneumocytes, peripheral blood mononuclear cells, and in Ishikawa endometrial cells [16, 17, 18] . A recent study showed genital infection in the murine model, demonstrating a systemic burden of bacteria that spreads to various organs e.g. vagina, spleen, and lumbar lymph nodes [19] . The infamy of the organism is not only limited to the diseases of reproductive systems as other studies implicated its role in respiratory infections [20, 21] . A possible mode of transmission zoonotic exposure [11, 22] which is unsurprising as the bacteria has also been implicated in its role in bovine abortion [16, 23] . Although it has been reported that W. chondrophila was susceptible to generic drugs e.g. doxycycline & azithromycin and resistant to β-lactams & fluoroquinolones in cell cultures [24] , no official drug is present for this organism to this date. Unfortunately, it is common for pathogens to acquire resistance against antibiotics [25] . Taking into account the possibility of antibiotic resistance over time and considering the damage caused by the organism, rapid actions are required to develop a therapeutic strategy at an early stage to combat this pathogen.

Subtractive proteomics analysis is a well-devised approach used to detect novel drug targets in the pathogen [26, 27] . In recent years, subtractive proteomics is efficiently used to discover species-specific vaccine candidates and in determining potential drug targets against various pathogenic bacteria [28, 29, 30] . To bypass the cross-reactions of drugs and specifically targeting a pathogenic entity subtractive proteomics has been seen to be especially helpful [29] . Further using this data, in-silico, in-vitro and in-vivo experiments can be employed to discover novel information on the organism. Conventional approaches to drug exploration and advancements are strenuous, sluggish, and expensive [31] . To reduce these drawbacks, in-silico methods can be employed as an alternative approach thereby facilitating numerous discoveries [28, 29, 30, 32, 33, 34, 35] . These methods are dynamic, rapid, and cost-effective than traditional drug discovery and development methods [31] . In-silico drug discovery methods exploit 'omics' data (i.e. genomics, proteomics, and metabolomics) and have been efficiently used for determining appropriate therapeutic drug targets in diverse infectious microorganisms such as bacteria and fungi. Drug repositioning, a strategy for discovering unprecedented uses for approved or investigational drugs that are not within the scope of the original medical indication [36] , can also potentially lower the time-frame and monetary investment for drug development and most importantly reduce the chances of failure [37] . An example of drug repositioning is Zidovudine, the first anti-HIV drug approved by the Food and Drug Administration (FDA), which was originally intended to use for cancer treatment [37] .

The current study combined and implemented the state of the art techniquessubtractive proteomics, molecular docking, and drug repositioning and, in turn, identified druggable proteins of W. chondrophila along with prospective repositioned drug against one of the druggable protein candidates namely UDP -N-acetylenol pyruvoyl glucosamine. We hope that the findings of this study will pave the way for further research and can provide sufficient foundations for designing a specific therapeutic regime against this pernicious pathogen.

The whole proteome (excluding plasmid proteins) of W. chondrophila was retrieved from UNIPROT (proteome id: UP000001505). To remove the paralogous sequences, the proteins were subjected to CD-HIT server [38] (¼http://weizhong-lab.ucsd.edu/cdhit-web-server/cgi-bin/inde x.cgi?cmdcd-hit) to identify proteins with 60% sequence identity cut-off using the global sequence identity algorithm and keeping the rest of the parameters as default. The server curated a protein subset (PSet1) that contained non-duplicate sequences under the aforementioned constraints. Important bacterial sequences were retrieved from different databases such as The Database of Essential Genes [39] (DEG) (http://tu bic.tju.edu.cn/deg/), The Virulence Factor Database [40] (VFDB) (http://www.mgc.ac.cn/VFs/download.htm), and The Antibiotic Resistance Gene-ANNOTation [41] (ARG-ANNOT) database (AA V6 July 2019) (https://www.mediterranee-infection.com/acces-ressources/bas e-de-donnees/arg-annot-2/). PSet1 proteins were subjected to standalone BLAST [42] (v 2.6.0þ) against the obtained protein sequences from DEG, ARG-ANNOT, VFDB with a cut-off of e-value < 1e-4 and bit score >100 to determine the important proteins. The matched results against DEG, ARG-ANNOT, VFDB protein contained some overlap. Taking an entry once, the results collectively constructed a new protein set (PSet2) which contained all the unique entries.

NCBI BLASTp [43] (¼https://blast.ncbi.nlm.nih.gov/Blast.cgi?PAG EProteins) was performed against the human proteome (taxid: 9606) with an e-value of 1e-10 using the PSet2. A new protein set (PSet3) was developed subtracting the BLAST matches with human proteins from PSet2. Afterward, PSet3 was provided to KEGG Automatic Annotation Server (KAAS) [44, 45] (https://www.genome.jp/kegg/kaas/) to perform functional annotation of proteins against the manually curated KEGG GENES of W. chondrophila using bi-directional best hit algorithm. The results generated from the server contained KEGG Orthology (KO) assignments as well as automatically generated KEGG pathway assignments (by assigning proteins to pathways with preset K-ids). Information regarding metabolic pathways of W. chondrophila and Homo sapiens were obtained from the Kyoto Encyclopedia of Genes and Genomes (KEGG) database. Using the K-ids given in the database pathogen-specific pathways were identified. Thereafter, proteins unique to each pathogen-specific pathway were identified using KO-ids (assigned by KAAS) which collectively constructed a metabolic pathway-dependent protein subset (PSet-PD). Also, by comparing the K-ids of metabolic pathways of W. chondrophila from KEGG database against the KEGG BRITE results obtained from KAAS, metabolic pathway independent proteins (PSet-PI) were identified manually.

To evaluate the druggability of the proteins (PSet-PD & PSet-PI), a standalone BLAST search was done against FDA-approved drug targets obtained from the DrugBank [46] (https://www.drugbank.ca/) database (as of 2020-07-02) with a cut-off of e-value < 0.005 and bit >100. An important thing to note is that there is no pre-established rule on how to set the BLAST cutoff criteria. Rather a general rule of thumb was followed where cut-offs were always kept in moderate range as a too stringent or too relaxed cutoff will generate higher false negative or false positive results respectively, a strategy seemed to be employed by other research groups as well [28, 29] .

Subcellular localization using PSORTb [47] (https://www.psort.or g/psortb/) and CELLO [48, 49] (http://cello.life.nctu.edu.tw/), Molecular weight using Compute pI/Mw tool [50] (https://web.expasy.org/co mpute_pi/), 3D structures using SWISS-MODEL [51] (https://swi ssmodel.expasy.org/) were determined for druggable proteins. Quality control for modeled structures was done with the aid of GMQE & QMEAN scores of SWISS-MODEL as well as the Ramachandran plots generated from PROCHECK server [52] (https://servicesn.mbi.ucla.edu/ PROCHECK/).

The structure of UDP-N-acetylenol pyruvoyl glucosamine reductase (MurB) was based on the template PDB ID: 4PYT [53] (https://www.rcsb .org/structure/4PYT). The modeled protein was minimized in the GROMOS96 force field of Swiss PDB Viewer [54] The entire workflow in the methodology was provided as an illustration ( Figure 1 ).

The proteome of W. chondrophila contained 1899 proteins. PSet1 was generated by removing 77 paralogous duplicate sequences using the CD-HIT [38] server. BLAST against databases of DEG [39] , ARG-ANNOT [41] , and VFDB [40] showed 653, 32, and 130 matches respectively totaling out 676 unique hits (PSet2) (see Table 1 ).

NCBI BLAST [43] search against the human proteome revealed 453 hits, which were excluded from further analysis, constituting PSet3 with 223 proteins. Comparing the metabolic pathways (KEGG database) of W. chondrophila and Homo sapiens, 22 pathways were found to be the Waddlia specific (Supplementary Table 1 ). KAAS [45] annotation assigned 65 pathways to the proteins provided to the server. Using bacteria-specific pathway data (Supplementary Table 1 ) from KEGG database, 14 were found unique to the bacteria among the 65 assigned pathways by KAAS annotation. Using the assigned K-ids of pathways and KO-ids of proteins, forty-eight proteins (PSet-PD) were selected (Table 1,  Supplementary Table 2 ) for further analysis that were absent in multiple pathways among the 14.

Waddlia specific pathways. Also, KEGG BRITE data (from KAAS server) contained 61 K-id assignments to 70 proteins (PSet-PI), which were metabolic pathway independent (Table 1, Supplementary Table 3) . These proteins were additionally kept for further analysis.

Search against the DrugBank [46] database using PSet-PD and PSet-PI showed eight matches ( Table 2 ). The resultant druggable proteins were as follows -Riboflavin synthase, alpha subunit (D6YVD7), Putative cytochrome d ubiquinol oxidase subunit 2 (D6YVJ2), Chorismate synthase (D6YWA2), Glycerol-3-phosphate dehydrogenase [NAD(P)þ] (D6YST7), Putative D-alanyl-D-alanine carboxypeptidase (D6YS23), UDP-N-acetylenol pyruvoyl glucosamine reductase (D6YVJ9), DNA topoisomerase (D6YVX0), Putative multidrug resistance protein MdtC (D6YSV9). Among the eight proteins, DNA topoisomerase and Putative multidrug resistance protein MdtC were metabolic pathways independent and the rest were metabolic pathways dependent. DrugBank database targets and their corresponding drugs were also provided along with the matched Waddlia proteins (Tables 1 and 2 ).

Additional information for the eight druggable proteins PSORTb [47] , CELLO [48, 49] , and Compute pI/Mw tool [51] summarized and provided (Supplementary Table 4 ). Employing homology modeling, the 3D structures of the eight proteins were constituted on SWISS-MODEL. GMQE and QMEAN4 values of SWISS-MODEL [51] were considered to develop the model and Ramachandran plot from PROCHECK [52] server results were taken into consideration for the validation of the predicted models ( Figure 2 ; Supplementary Table 5 ). Models with below 90% of residues under acceptable regions were excluded from the further studies.

Virtual screening against UDP-N-acetylenol pyruvoyl glucosamine reductase (MurB; UNIPROT: D6YVJ9), showed various compound which showed higher affinity than the control FAD (-9.5 kcal/mol). Bupivacaine hydrochloride (L1; CHEMBL3288678; -12.0 kcal/mol), Nilotinib hydrochloride monohydrate (L2; CHEMBL255863; -11.5 kcal/mol), Regorafenib (L3; CHEMBL1946170; -11.4 kcal/mol) are the top three ligands which were finally selected for a more comprehensive analysis. The resulting interactions of these ligands and corresponding graphical representations were provided (Figures 3 and 4; Supplementary Table 6 ).

The control molecule (FAD) interacted with LYS56, SER94, SER96, ARG104, SER209, GLY115, THR18, ARG97, PRO117, ALA100 residues of the protein. L1 showed interactions with GLY129, ILE116, ALA210, GLY211, MET126, ALA128, and PRO117 among which GLY129 was the only one forming hydrogen bond and the rest of them are various hydrophobic interactions. There was only a single unfavorable bond with THR119 at a distance of 2.05218 Å. Although L1 shows fewer interactions compared to control, it had the highest binding affinity with a 

W. chondrophila is an emerging pathogen associated with both human and bovine disease [6, 7] . An study conducted by Baud et al. on 69 women with sporadic miscarriages, 200 with recurrent miscarriages and 169 control women with uneventful pregnancies, comprising a total of 438 women, the seroprevalence of anti-Waddlia IgG for women with sporadic miscarriages, recurrent miscarriages and control women 31.9%, 33%, and 7% respectively [11] . Overtime other studies documented the association of this bacteria in unpropitious pregnancy events [9, 10, 12, 13] . Due to the absence of commercially available standardized methods for the detection W. chondrophila in patients, the actual epidemiology is still not available. The possible modes of transmission can be zoonotic exposure, ingestion of contaminated meat or milk [11] . The water networks were also proposed to as the presence of W. chondrophila was detected in well water samples [59] . Considering the mode of transmissions mass order abortions can be possibility with women working in the farm and dairy industry being at the highest risk. The a priori clinical preparations are necessary in order to fight off such pathogens an attempt to which is the overarching goal of the current study.

In the study, the chromosomal proteins were first retrieved from UNIPROT. As it can abandoned by the organism under selection pressure, the utility of plasmid proteins for the purpose of this study was questionable and therefore excluded beforehand. Generally, a large protein dataset contains sequences that are highly similar (paralogous), and removing them reduces the volume of search space thereby saving time and computational resources. CD-HIT was used to remove the 77 duplicate sequences within the proteome that had >60% similar or related structure and function with other proteins in the proteome. This reduced the redundancy of the data constructing the protein subset PSet1.

To identify the important proteins of W. chondrophila, the aid of various databases was taken. The Database of Essential Genes (DEG) contains experimentally identified protein sequences that are indispensable for the organism. The Antibiotic Resistance Gene-ANNOTation (ARG-ANNOT) contains database consists of a single file covering nucleotide/protein sequences in FASTA format from all antibiotic classes. This is used to identify extant and putative new antibiotic resistance (AR) genes in bacterial genomes. The virulence factor database (VFDB) is a combined and extensive online resource for curating information about virulence factors of bacterial pathogens. Virulence factors are molecular entities that ameliorate bacterial colonization, immunosuppression, immunoevasion, etc. within the host, thereby facilitating the process of disease. Standalone BLAST searches against these databases helped to construct the PSet2 protein dataset containing 676 important proteins of the bacteria.

Even though PSet2 is important to bacteria, not all of them can be used as a drug target as some of the protein can potentially be associated with the metabolic pathway of the host. Targeting those proteins may eventually cause host toxicity & cross-reactions. KEGG Automatic Annotation Server or KAAS annotations were used to circumvent this issue. KEGG (Kyoto Encyclopedia of Genes and Genomes) is a database resource for understanding high-level functionalities of biological systems with the aid of molecular-level information like high throughput sequencing or other experimental datasets. Metabolic pathway information of W. chondrophila and its host Homo sapiens are enlisted in the KEGG database with their respective K-ids. The pathways were retrieved from the database and compared manually to identify pathogen-specific pathways. Afterward, KO-ids were used to identify proteins that are present in only one pathway. This resulted in the PSet-PD dataset with 48 protein entries. KAAS annotation also gives information about KEGG BRITE, which is a collection of hierarchical classification systems encapsulating functional hierarchies of various biological objects. This contains additional information on proteins that are not metabolic pathway-dependent yet they perform key roles in biological systems. Using this information 70 metabolic pathway independent proteins (PSet-PI) were identified through manual search. Considering both the pathway dependent and independent proteins allow for addressing a broader range of targets within the microorganism hence enhancing the chances of identifying substantial druggable candidates. Sequence similarity with a previously known drug target would facilitate the drug searching process immensely, aiding the rational drug discovery & repurposing/repositioning process. Therefore, PSet-PI & PSet-PD proteins were subjected to the standalone BLAST search against the DrugBank database. The DrugBank (https://www.drugbank.ca/) is a comprehensive online database, which accommodates a massive amount of data on drugs and drug targets. High similarity with FDA approved drug targets present in the database allows for a much safer and more specific therapeutic regime. Only eight proteins matched the cut-off criteria strictly (Table 2) independent. PSORTb and CELLO servers were used to predict the subcellular localization and the Compute pI/Mw tool was used to obtain the molecular weight (Supplementary Table 4 ) of the eight proteins that will help in formulating the drug delivery strategy. These druggable proteins play a myriad of crucial roles in the organism and the following are some of the highlights -Riboflavin synthase catalyzes riboflavin biosynthesis in bacteria [60] . Riboflavin is an indispensable micronutrient which acts as cofactor for numerous flavoproteins either directly or through derivatized form [61] . Cytochrome d ubiquinol oxidase participates in the reactions of the respiratory chain in many human-pathogenic bacteria. It is not structurally associated with mitochondrial cytochrome c oxidases and found exclusively on prokaryotes [62] . Biosynthesis of various aromatic compounds depends on the shikimate pathway which are responsible for electron transport, signaling, communication etc. Chorismate synthase is the seventh enzyme of the shikimate pathway which catalyzes the synthesis of chorismate from 5-enolpyruvylshikimate 3-phosphate. The enzyme has an absolute prerequisite of reduced flavin adenine mononucleotide as co-factor for function [63] . Glycerol-3-phosphate dehydrogenase breaks down glycerol-3-phosphate and produces energy [64] . D-alanyl-D-alanine carboxypeptidases are members of penicillin-binding proteins (PBPs) which are generally involved in peptidoglycan biosysnthesis. PBPs are sensitive to β-lactam antibiotics and constitute a family of acyltransferases with a unified evolutionary origin [65] . DNA topoisomerases are involved in controlling the topology of the DNA in the cellular environment. They exert their enzymatic prowess by causing transient single/double strand breakage in DNA which stabilizes DNA-protein covalent binding [66] . Multidrug resistant proteins belongs to the major facilitator superfamily [67, 68] which confers antibiotic resistance to bacteria upon overexpression [69] . These proteins also provide protection against a myriad environmental toxins through active extrusion of the pernicious compounds [70] . Finally, UDP-N-acetylenol pyruvoyl glucosamine reductase (MurB) is the product of murB gene which catalyzes the terminal steps of the formation of UDP-N-acetylmuramic acid in the peptidoglycan biosynthesis pathway [71] . The experimental structures of the eight selected proteins were absent in UNIPROT. Hence, the three-dimensional structures of the eight proteins were modeled using SWISS-MODEL, which is a fully automated service that uses homology-modeling to predict reliable protein models. For each protein, a template search was done followed by model construction. Predicted models that possessed the highest GMQE & QMEAN were taken for further analysis (Supplementary Table 5 ). To validate the reliability of the predicted models, Ramachandran plots were generated for all the models using the PROCHECK server. Two models were not found reliable as they did not have the minimum 90% residues inside the acceptable region (Supplementary Table 5 ). Subsequently, the study was geared towards identifying drug molecules that can effectively inhibit the critical proteins of W. chondrophila. Even though from a functional perspective all six protein candidates were prominent drug targets, the rest of the study only focused on MurB for the following reasons -Due to its involvement in peptidoglycan biosynthesis, MurB a prominent target against bacteria especially against its cell wall, and various researches had taken place on this protein to discover the inhibition strategy [72, 73, 74, 75] . Although putative D-alanyl-D-alanine carboxypeptidase was related to peptidoglycan biosynthesis pathway, the unsuccessful prediction of the structure led to exclusion of the protein from virtual docking study. Also, 4PYT was the only template structure that contained co-enzyme bound in the crystal structure which was eventually used to guide the ligand-binding site for virtual screening.

To implement the drug repositioning strategy, the FDA approved drugs obtained from BindingDB [56] were used in virtual screening. Using FDA-approved drugs has several advantages over using a random pool of drugs. For example, FDA approved drugs already have known indications and contraindications, which facilitates the administration process. For a large chunk of these drugs, their interaction network is known which also helps in using the drug field trials. This can allow for a more precise target search thereby accelerating the overall novel target discovery workflow. As FAD is co-factor of MurB, it served as the control in the study for molecular docking. Virtual screening using the FDA approved drug candidates identified various drugs that have a higher binding affinity than its co-factor FAD. Bupivacaine hydrochloride (L1), Nilotinib hydrochloride monohydrate (L2), and Regorafenib (L3) were the top three identified ligands with binding affinity -12.0 kcal/mol, -11.5 kcal/mol, and -11.4 kcal/mol respectively. L1 is a local anesthetic [76] that causes absence of pain sensation in a specific location of the body. It can be cardiotoxic [77] , and able to shows dose dependent cytotoxicity [78] and arrhythmia [79] . L2 is a potent selective inhibitor of the BCR-ABL tyrosine kinase [80] used in the treatment of chronic myeloid leukemia that is resistant to imatinib. Some of side effects associate with L2 includes cardiotoxicity [81] , elevated lipase and/or amylase levels, pancreatitis, hyperglycemia [82] etc. L3 is a diphenylurea multikinase inhibitor acting on VEGFR1-3, c-KIT, TIE-2, PDGFR-β, FGFR-1, RET, RAF-1, BRAF, and p38 MAP kinase [83] . L3 can cause cardiotoxicity [84] , rash, alopecia, desquamation, fatigue, mucositis, hypertension, diarrhea, thyroid dysfunction [83] . L2 & L3 are used as anticancer agents that generally have higher adverse effects [81, 82, 85] . On the other hand, L1 has a favorable potency to toxicity ratio [86] . Therefore, we propose that primarily L1, followed by L2 and L3 as repositionable drugs for the MurB protein. Also, the structure of L1, L2 and L3 can be taken as a scaffold and newer drugs can be developed which has lower toxicity but higher inhibitory property.

In conclusion, an extensive computational approach had been taken in this study to narrow down the most 8 druggable proteins of W. chondrophila appropriate and three inhibitory compounds were proposed for one of those druggable proteins, MurB, using drug repositioning and virtual screening. Finally, further experimental validations are necessary to establish these findings and use proposed drugs and drug targets for clinical purposes.

Umar Faruq Chowdhury: Conceived and designed the experiments; Performed the experiments; Analyzed and interpreted the data; Contributed reagents, materials, analysis tools or data; Wrote the paper.

Abdullah Al Saba: Performed the experiments; Analyzed and interpreted the data; Contributed reagents, materials, analysis tools or data; Wrote the paper.

Abu Sufian Sufi: Performed the experiments; Analyzed and interpreted the data; Wrote the paper.

Akib Mahmud Khan, Ishrat Sharmin, Aziza Sultana, Md Ohedul Islam: Contributed reagents, materials, analysis tools or data; Wrote the paper.

This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

Data included in article/supplementary material/referenced in article.

The authors declare no conflict of interest.

Supplementary content related to this article has been published online at https://doi.org/10.1016/j.heliyon.2021.e07320.

Population biology of emerging and re-emerging pathogens

Climate change and human health: present and future risks

Environmental and social influences on emerging infectious diseases: past, present and future

Infectious diseases that pose specific challenges after natural disasters: a review

Emerging pathogens in infectious diseases: definitions, causes and trends

Waddlia: an emerging pathogen and a model organism to study the biology of chlamydiae

Waddlia chondrophila: from biology to pathogenicity

Waddlia chondrophila infects and multiplies in ovine trophoblast cells stimulating an inflammatory immune response

Role of Waddlia chondrophila placental infection in miscarriage

Emerging role of Chlamydia and Chlamydia-like organisms in adverse pregnancy outcomes

Waddlia chondrophila, a potential agent of human fetal death

Role of Chlamydia trachomatis and emerging Chlamydia-related bacteria in ectopic pregnancy in Vietnam

Waddlia chondrophila and Chlamydia trachomatis antibodies in screening infertile women for tubal pathology

Waddlia chondrophila, a Chlamydia-related bacterium, has a negative impact on human spermatozoa

Neospora caninum and Waddlia chondrophila strain 2032/99 in a septic stillborn calf

Permissivity of Vero cells, human pneumocytes and human endometrial cells to Waddlia chondrophila

Early intracellular trafficking of Waddlia chondrophila in human macrophages

Waddlia chondrophila induces systemic infection, organ pathology, and elicits Th1-associated humoral immunity in a murine model of genital infection

Development of a real-time PCR for the specific detection of Waddlia chondrophila in clinical samples

Chlamydia-like bacteria in respiratory samples of community-acquired pneumonia patients

First detection of Waddlia chondrophila in Africa using SYBR Green real-time PCR on veterinary samples

Results of a new serologic test suggest an association of Waddlia chondrophila with bovine abortion

Antibiotic susceptibility of Waddlia chondrophila in Acanthamoeba castellanii amoebae

Antibiotic resistance

Subtractive genome analysis for in silico identification and characterization of novel drug targets in Streptococcus pneumonia strain JJA

Prioritization of potential drug targets against P. aeruginosa by core proteomic analysis using computational subtractive genomics and Protein-Protein interaction network

Subtractive proteomics to identify novel drug targets and reverse vaccinology for the development of chimeric vaccine against Acinetobacter baumannii

Application of the subtractive genomics and molecular docking analysis for the identification of novel putative drug targets against Salmonella enterica subsp. enterica serovar poona

Subtractive genomics, molecular docking and molecular dynamics simulation revealed LpxC as a potential drug target against multi-drug resistant Klebsiella pneumoniae

Natural products in drug discovery

Computational design of potential siRNA molecules for silencing nucleoprotein gene of rabies virus

A computational approach to design potential siRNA molecules as a prospective tool for silencing nucleocapsid phosphoprotein and surface glycoprotein gene of SARS-CoV-2

Human intestinal defensin 5 inhibits SARS-CoV-2 invasion by cloaking ACE2

Bioinformatics approaches for anti-cancer drug discovery

Drug repositioning: identifying and developing new uses for existing drugs

Drug repurposing: progress, challenges and recommendations

CD-HIT Suite: a web server for clustering and comparing biological sequences

Gene essentiality analysis based on DEG 10, an updated database of essential genes

VFDB: a reference database for bacterial virulence factors

ARG-annot, a new bioinformatic tool to discover antibiotic resistance genes in bacterial genomes

BLASTþ: architecture and applications

NCBI BLAST: a better web interface

KEGG: Kyoto Encyclopedia of genes and genomes

KAAS: an automatic genome annotation and pathway reconstruction server

PSORTb 3.0: improved protein subcellular localization prediction with refined localization subcategories and predictive capabilities for all prokaryotes

Prediction of protein subcellular localization

Predicting subcellular localization of proteins for Gram-negative bacteria by support vector machines based on n -peptide compositions

The Proteomics Protocols Handbook

SWISS-MODEL: an automated protein homology-modeling server

PROCHECK: a program to check the stereochemical quality of protein structures

a versatile new fluorescent reporter protein

Defining and searching for structural motifs using DeepView/Swiss-PdbViewer

AutoDock 4 and AutoDockTools 4: automated docking with selective receptor flexibility

BindingDB in 2015: a public database for medicinal chemistry, computational chemistry and systems pharmacology

Open Babel: an open chemical toolbox

AutoDock Vina, Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading

Well water as a possible source of Waddlia chondrophila infections

Crystal structure of riboflavin synthase

Overlapping riboflavin supply pathways in bacteria

Active site rearrangement and structural divergence in prokaryotic respiratory oxidases

A unique reaction in a common pathway: mechanism and function of chorismate synthase in the shikimate pathway

Active transport of l-alpha-glycerophosphate in Escherichia Coli

Characterization of SCO4439, a D-alanyl-D-alanine carboxypeptidase involved in spore cell wall maturation, resistance, and germination in Streptomyces coelicolor

Multidrug resistance in bacteria

Proton-dependent multidrug efflux systems

AcrAB efflux pump plays a major role in the antibiotic resistance phenotype of Escherichia coli multiple-antibiotic-resistance (Mar) mutants

The BaeSR two-component regulatory system activates transcription of the yegMNOB (mdtABCD) transporter gene cluster in Escherichia coli and increases its resistance to novobiocin and deoxycholate

Structure based drug designing and discovery of promising lead molecules against UDP-N-acetylenolpyruvoylglucosamine reductase (MurB): a potential drug target in multidrug resistant Acinetobacter baumannii

Structure-based virtual screening, free energy of binding and molecular dynamics simulations to propose novel inhibitors of Mtb-MurB oxidoreductase enzyme

Novel bis(pyrazole-benzofuran) hybrids possessing piperazine linker: synthesis of potent bacterial biofilm and MurB inhibitors

Discovery of the first antibacterial small molecule inhibitors of MurB

4-Thiazolidinones, Novel inhibitors of the bacterial enzyme MurB

Use of bupivacaine hydrochloride in oral surgery-a clinical study

Bupivacaine and levobupivacaine induce apoptosis in rat chondrocyte cell cultures at ultra-low doses

Estudio Comparativo entre la Bupivacaína (S75-R25) y la Ropivacaína para Evaluar la Seguridad Cardiovascular en el Bloqueo del Plexo Braquial

Nilotinib is effective in patients with chronic myeloid leukemia in chronic phase after imatinib resistance or intolerance: 24-month follow-up results

Multi-parameter in vitro toxicity testing of crizotinib, sunitinib, erlotinib, and nilotinib in human cardiomyocytes

Nilotinib-associated vascular events

Regorafenib for cancer

Extended regorafenib treatment can be linked with mitochondrial damage leading to cardiotoxicity

Risk of cardiovascular toxicities in patients with solid tumors treated with sunitinib, axitinib, cediranib or regorafenib: an updated systematic review and comparative meta-analysis

Bupivacaine: a review